iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionMutual Advisors, LLC
Latest Disclosed Ownership2,906 shares
Latest Disclosed Value $ 490,702
Mutual Advisors, LLC reports 68.81% decrease in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 1, 2026 - Mutual Advisors, LLC filed a 13F-HR form disclosing ownership of 2,906 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $490,702 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 9,317 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of -68.81% during the quarter. The current value of the position is $380,831 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,906 -6,411 -68.81 491 -68.83 0.0105
2026-02-02 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 9,317 3,008 47.68 1,572 61.23 0.0337
2025-11-04 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 6,309 -1,421 -18.38 975 -6.88 0.0215
2025-07-28 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 7,730 -1,359 -14.95 1,047 -6.43 0.0262
2025-04-28 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 9,089 -211 -2.27 1,120 -9.47 0.0321
2025-01-17 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 9,300 -300 -3.12 1,236 -9.05 0.0358
2024-10-25 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 9,600 -108 -1.11 1,359 -5.30 0.0397
2024-07-30 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 9,708 -1,100 -10.18 1,436 -3.24 0.0433
2024-05-02 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 10,808 747 7.42 1,483 8.57 0.0476
2024-01-12 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 10,061 -1,626 -13.91 1,367 -4.41 0.0476
2023-11-13 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 11,687 -12,579 -51.84 1,429 -53.60 0.0557
2023-07-31 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 24,266 1,702 7.54 3,081 5.70 0.1169
2023-04-11 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 22,564 -672 -2.89 2,914 -4.46 0.1196
2023-01-12 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 23,236 -379 -1.60 3,051 10.43 0.1365
2022-11-03 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 23,615 1,762 8.06 2,762 7.43 0.1421
2022-08-15 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 21,853 -1,920 -8.08 2,571 -17.01 0.1702
2022-05-09 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 23,773 3,978 20.10 3,098 2.55 0.1734
2022-02-14 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 19,795 251 1.28 3,021 -4.40 0.1599
2021-11-15 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 19,544 4,393 28.99 3,160 27.42 0.1870
2021-08-12 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 15,151 2,183 16.83 2,480 27.05 0.1471
2021-05-13 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 12,968 -143 -1.09 1,952 -1.71 0.1335
2021-02-11 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 13,111 -171 -1.29 1,986 10.46 0.1475
2020-11-13 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 13,282 105 0.80 1,798 -0.17 0.1559
2020-08-05 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 13,177 -368 -2.72 1,801 23.44 0.1770
2020-05-13 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 13,545 284 2.14 1,459 -8.70 0.1979
2020-02-11 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 13,261 650 5.15 1,598 27.33 0.1700
2019-11-01 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 12,611 92 0.73 1,255 -8.13 0.1658
2019-08-15 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 12,519 -9 -0.07 1,366 -2.50 0.1775
2019-05-15 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 12,528 650 5.47 1,401 22.36 0.2074
2019-02-15 2018-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 11,878 -104 -0.87 1,145 -21.63 0.2256
2018-11-15 2018-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 11,982 2,755 29.86 1,461 44.23 0.2218
2018-08-15 2018-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 9,227 48 0.52 1,013 3.37 0.2310
2018-05-11 2018-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 9,179 1,248 15.74 980 15.70 0.2484
2018-02-12 2017-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 7,931 7,931 847 0.3198
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.